Comparison of Prostate-Specific Promoters and the Use of PSP-Driven Virotherapy for Prostate Cancer

Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer deaths in men today. Although virus-based gene therapy is a promising strategy to combat advanced prostate cancer, its current effectiveness is limited partially due to inefficient cellular transduction in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yi, Zhang, Yu, Chang, Guimin, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581130/
https://www.ncbi.nlm.nih.gov/pubmed/23484134
http://dx.doi.org/10.1155/2013/624632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581130/
https://www.ncbi.nlm.nih.gov/pubmed/23484134
http://dx.doi.org/10.1155/2013/624632

Ejemplares similares